Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Translocation Machinery on the ER Membrane01:28

Protein Translocation Machinery on the ER Membrane

6.9K
The translocon complex situated on the ER membrane is the main gateway for the protein secretory pathway. It facilitates the transport of nascent peptides into the ER lumen and their insertion into the ER membrane.
Sec61 protein conducting channel
In eukaryotes, the translocon complex comprises a core heterotrimeric translocator channel called the Sec61 complex. This channel includes three transmembrane proteins, Sec61α, Sec61β, and Sec61γ, and is the largest subunit of the...
6.9K
Cellular Membranes and Drug Transport01:24

Cellular Membranes and Drug Transport

1.7K
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
1.7K
What are Viruses?00:50

What are Viruses?

128.5K
Overview
128.5K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

282
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
282
Hepatic Portal System01:21

Hepatic Portal System

6.4K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
6.4K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

256
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
256

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Antarctic radar on Southern Hemisphere atmospheric river reanalysis and forecast.

Scientific reports·2026
Same author

Leucine-Restricted Diet Attenuates Small Intestinal Tumorigenesis in Apc<sup>Min</sup> <sup>/+</sup> Mice.

Food science & nutrition·2026
Same author

Nationwide Detection and Molecular Characterization of Hepatitis E Virus RNA in Retail Pork Meat in Japan.

Viruses·2026
Same author

Lysosomal lipid metabolism promotes tumor cell invasion through local energetics and membrane lipid remodeling.

bioRxiv : the preprint server for biology·2026
Same author

Secretion of the HBV small surface antigen is driven by an ER autophagic pathway.

Hepatology communications·2026
Same author

ADAMDEC1 is not a driver of intestinal fibrosis but a marker of the inflammation-stromal niche in Crohn's disease.

Biochemical and biophysical research communications·2026

Related Experiment Video

Updated: Feb 15, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.7K

Cellular Membrane Trafficking Machineries Used by the Hepatitis Viruses.

Jun Inoue1, Masashi Ninomiya1, Tooru Shimosegawa1

  • 1Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Hepatology (Baltimore, Md.)
|January 14, 2018
PubMed
Summary

Hepatitis viruses hijack host cell membrane trafficking for replication. Understanding these pathways, especially for Hepatitis B virus (HBV), is crucial for developing new treatments for liver diseases.

More Related Videos

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
06:28

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus

Published on: October 1, 2015

14.1K
Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

7.9K

Related Experiment Videos

Last Updated: Feb 15, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.7K
Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
06:28

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus

Published on: October 1, 2015

14.1K
Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

7.9K

Area of Science:

  • Virology
  • Cell Biology
  • Hepatology

Background:

  • Hepatitis viruses (A-E) utilize host cell machinery for replication.
  • Hepatitis B virus (HBV) and Hepatitis C virus cause cirrhosis and liver cancer.
  • Effective treatments exist for Hepatitis C, but HBV requires lifelong management.

Purpose of the Study:

  • To review recent findings on cellular membrane trafficking pathways exploited by HBV.
  • To contextualize HBV's mechanisms within those of other hepatitis viruses.

Main Methods:

  • Review of current literature on hepatitis virus life cycles.
  • Focus on host cell membrane trafficking, including endocytosis and the multivesicular body.

Main Results:

  • Hepatitis viruses hijack host secretory and endocytic pathways.
  • Clathrin-mediated endocytosis and specific cell surface receptors are involved.
  • Multivesicular bodies and endosomal sorting complexes are implicated in viral envelopment.

Conclusions:

  • Understanding host-pathogen interactions in membrane trafficking is key to combating viral hepatitis.
  • Further research into HBV's specific cellular pathway utilization is essential for therapeutic advancements.